SCHEMBL7079332

SCHEMBL7079332

O=C(c1cc2ccccc2[nH]1)c1ccc([N+](=O)[O-])cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 4/20 0.54
PDGFRB P09619 5/20 0.54
PDGFRA P16234 5/20 0.54
KMT2A Q03164 3/20 0.51
MAPK1 P28482 2/20 0.48
GAA P10253 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
FGFR1 P11362 1/20 0.47
SRC P12931 1/20 0.47
FGFR2 P21802 1/20 0.47
FGFR4 P22455 1/20 0.47
FGFR3 P22607 1/20 0.47
KDR P35968 1/20 0.47
POLB P06746 2/20 0.46
MEN1 O00255 2/20 0.46
NPC1 O15118 2/20 0.46
MAPT P10636 3/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076298 0.79 FLT3 (0.59) FLT3PDGFRBPDGFRAKMT2AMAPK1
SCHEMBL30151584 0.79 HRH4 (0.49) FLT3PDGFRBPDGFRAKMT2APOLB
SCHEMBL7079685 0.76 CYP1A2 (0.58) KMT2AMAPK1GAAHTTNPSR1
SCHEMBL5537378 0.76 KMT2A (0.56) KMT2AMAPK1GAAHTTNPSR1
SCHEMBL6314599 0.76 MAPK1 (0.68) KMT2AMAPK1GAAHTTNPSR1
SCHEMBL27885276 0.75 HRH4 (0.61) FLT3PDGFRBPDGFRAKMT2APOLB
SCHEMBL31065643 0.75 FLT3 (0.69) FLT3PDGFRBPDGFRAKMT2AMAPK1
SCHEMBL31060426 0.72 FLT3 (1.00) FLT3PDGFRBPDGFRAMAPK1GAA
SCHEMBL370573 0.72 FLT3 (1.00) FLT3PDGFRBPDGFRAMAPK1GAA
SCHEMBL5173228 0.72 MAPK13 (0.61) KMT2AMAPK1GAAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed
WO-2002083622-A2 NOVEL AMINOPHENYL KETONE DERIVATIVES LEO PHARMA A/S (DK) 2002-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 FLT3 1230/4885PDGFRB 1342/4885PDGFRA 1528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.